Academics
follow us
  • Linkedin
  • Twitter
  • Facebook
  • Youtube
  • Instagram
Feedback
Patent Number:- IN201811017168

Compounds as Pro-inflammatory cytokine inhibitor

  • Sector: Pharmaceutical Technology,
  • IPC: C07C,
 

Need

Current anti-inflammatory agents pose risks of autoimmune responses and weakened immune defenses, necessitating safer and more effective alternatives.

Solution

The invention presents novel coumarin-based lignan compounds as potential therapeutic agents for treating chronic inflammatory conditions.

Innovation

The invention provides specific chemical compounds and processes for their synthesis, along with their use as anti-inflammatory agents and in pharmaceutical compositions for treating inflammatory diseases.

Market Analysis

Market: Anti-inflammatory drugs, especially for chronic inflammatory conditions

CAGR: Anticipated to be around 5-6%

Potential Indian Clients: Pharmaceutical companies focusing on research and development of anti-inflammatory drugs, contract research organizations (CROs) offering synthesis services

Why Invest?


Pro-inflammatory cytokine inhibitor

Chronic inflammatory conditions

Osteoarthritis

Cyto-toxicity

At a Glance


Current TRL: NA

Funded by: NA

IPC: C07C

Domain: Pharmaceutical Chemistry, Therapeutics

For more information, reach out to Mr. Rajneesh Kumar, Head of the Technology Transfer Office, at tto@bits-pilani.ac.in and 01596-255515.